Whalegun
Home

Sarepta Therapeutics SRPT paid Michael Best Strategies $110K for lobbying in Q1 2026 · Health Issues, Medical

Trade details

Type
Lobbying report
Amount
$110,000
Quarter
Q1 2026
Stock
Sarepta Therapeutics SRPT
Client
Sarepta Therapeutics
Reported
26/04/20

Up 0.0% from last quarter

What else happened in Sarepta Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Sarepta Therapeutics's other lobbying reports

  • Sarepta Therapeutics

    LobbyingSarepta Therapeutics

    $50K

    Reported 07/20

  • Sarepta Therapeutics

    LobbyingSarepta Therapeutics

    $90K

    Reported 07/20

  • Sarepta Therapeutics

    LobbyingSarepta Therapeutics

    $220K

    Reported 07/20

  • Sarepta Therapeutics

    LobbyingSarepta Therapeutics

    $270K

    Reported 04/20

  • Sarepta Therapeutics

    LobbyingSarepta Therapeutics

    $90K

    Reported 04/20

Sarepta Therapeutics SRPT paid Michael Best Strategies $110K for lobbying in Q1 2026 · Health Issues, Medical | Whalegun